We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Legend Biotech
LEGN
$3.31B
| $6.97M | 0.02% |
+163,872
| New | +$6.4M |
|
627
Conduent
CNDT
$252M
| $6.91M | 0.02% |
2,892,062
+1,363,712
| +89% | +$3.17M |
|
628
Radian Group
RDN
$4.67B
| $6.9M | 0.02% |
444,978
+191,521
| +76% | +$2.83M |
|
629
Tenable Holdings
TENB
$4.01B
| $6.89M | 0.02% |
230,999
+230,043
| +24,063% | +$6.25M |
|
630
Haemonetics
HAE
$4.83B
| $6.86M | 0.02% |
76,554
+60,888
| +389% | +$6.15M |
|
|
CTXS
631
DELISTED
Citrix Systems Inc
CTXS
| $6.78M | 0.02% |
45,870
-22,792
| -33% | -$3.28M |
|
632
Denali Therapeutics
DNLI
$3.21B
| $6.71M | 0.02% |
+277,463
| New | +$6.52M |
|
|
MANT
633
DELISTED
Mantech International Corp
MANT
| $6.7M | 0.02% |
97,748
+31,771
| +48% | +$2.34M |
|
|
WBT
634
DELISTED
Welbilt, Inc.
WBT
| $6.69M | 0.02% |
1,099,005
+474,823
| +76% | +$2.57M |
|
|
BHVN
635
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.69M | 0.02% |
+91,498
| New | +$4.87M |
|
636
Sabre
SABR
$936M
| $6.67M | 0.02% |
827,603
-570,619
| -41% | -$4.04M |
|
637
BioMarin Pharmaceuticals
BMRN
$12.5B
| $6.62M | 0.02% |
+53,690
| New | +$5.34M |
|
638
Grid Dynamics Holdings
GDYN
$651M
| $6.55M | 0.02% |
950,000
| – | – |
|
|
ICAD
639
DELISTED
iCAD Inc
ICAD
| $6.49M | 0.02% |
649,553
+500,000
| +334% | +$5.4M |
|
|
TGI
640
DELISTED
Triumph Group
TGI
| $6.48M | 0.02% |
719,202
+604,382
| +526% | +$4.47M |
|
|
CTEV
641
Claritev Corp
CTEV
$569M
| $6.47M | 0.02% |
+15,000
| New | +$6.05M |
|
642
Theravance Biopharma
TBPH
$884M
| $6.41M | 0.02% |
305,170
-95,804
| -24% | -$2.46M |
|
643
Commault Systems
CVLT
$6.02B
| $6.4M | 0.02% |
165,499
-169,734
| -51% | -$6.73M |
|
644
iShares MSCI India ETF
INDA
$6.44B
| $6.38M | 0.02% |
219,774
+2,865
| +1% | +$76.7K |
|
645
McKesson
MCK
$103B
| $6.37M | 0.02% |
41,527
+7,222
| +21% | +$1.04M |
|
646
Novavax
NVAX
$1.54B
| $6.37M | 0.02% |
76,379
+47,859
| +168% | +$1.83M |
|
|
SWT
647
DELISTED
Stanley Black & Decker, Inc.
SWT
| $6.36M | 0.02% |
71,126
| – | – |
|
|
RDFN
648
DELISTED
Redfin
RDFN
| $6.35M | 0.02% |
151,567
+150,592
| +15,445% | +$3.97M |
|
649
State Street
STT
$50.2B
| $6.32M | 0.02% |
99,484
-65,539
| -40% | -$3.96M |
|
|
SJR
650
DELISTED
Shaw Communications Inc.
SJR
| $6.32M | 0.02% |
386,055
+101,255
| +36% | +$1.67M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.